Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbaclofen for Social Function in Children and Adolescents with ASD
NCT03887676Phase 2Completed
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Start
- Mar 2019
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of arbaclofen in Autism Spectrum Disorder (ASD), sponsored by Holland Bloorview Kids Rehabilitation Hospital. Primary endpoint: Vineland Adaptive Behavior Scales, Third Edition - Social Domain at 16 weeks. Started Mar 2019; status: completed.
02
Drugs
arbaclofen
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03887676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887676.